… About ProQR Therapeutics An innovative biotech company advancing … Axiomer RNA-editing platform technology. We are ProQR We are ProQR We are ProQR, a biotechnology company dedicated to …
… ProQR founding story When our CEO, Daniel A. de Boer, knew … his newborn son had an incurable rare disease, he founded ProQR to help people like his son. Learn more. A personal … a difference in the world. Daniel continues to motivate ProQRians to remind them of the company’s mission and to …
… ProQR Analyst Event The live and archived webcast will be … - 17:00 - Do., 18.11.2021 - 19:00 During this webcast ProQR leadership will highlight key advancements from its …
On March 29, 2023 ProQR will host a virtual R&D event to showcase its proprietary Axiomer RNA-editing technology platform. ProQR will also announce initial pipeline targets for internal development.
… proprietary Axiomer RNA-editing platform technology. Our ProQRians, representing over 30 nationalities, are passionate … to change the lives of patients and their loved ones. ProQR Therapeutics is a biotech company with offices in …
… Version October 2022 Who we are In this Notice, the words “ProQR”, “We”, “Us” and “Our” refer to ProQR Therapeutics … (DPO) regarding any information, or concerns, related to ProQR’s processing of personal data, by sending an e-mail …
At ProQR we take care to give all applicants a good experience and value their time and interest in applying to become a ProQRian. On this page, you can find an overview of what you can expect throughout the recruitment process, until your first onboarding week.
